Haleon’s (HLN) “Hold” Rating Reaffirmed at HSBC

HSBC reiterated their hold rating on shares of Haleon (NYSE:HLN) in a report published on Wednesday morning, Marketbeat reports.

A number of other research firms have also weighed in on HLN. Sanford C. Bernstein lowered shares of Haleon from an “outperform” rating to a “market perform” rating in a report on Wednesday, January 8th. Morgan Stanley lowered shares of Haleon from an “overweight” rating to an “equal weight” rating in a report on Friday, January 10th. Four analysts have rated the stock with a hold rating, two have assigned a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, Haleon presently has an average rating of “Moderate Buy” and a consensus price target of $10.95.

Haleon Stock Performance

NYSE HLN opened at $10.55 on Wednesday. The company’s 50 day moving average is $9.63 and its 200-day moving average is $9.85. Haleon has a 12-month low of $7.89 and a 12-month high of $10.80. The company has a quick ratio of 0.58, a current ratio of 0.84 and a debt-to-equity ratio of 0.44. The firm has a market cap of $47.74 billion, a P/E ratio of 31.01, a price-to-earnings-growth ratio of 2.82 and a beta of 0.28.

Haleon (NYSE:HLN) last posted its quarterly earnings results on Thursday, February 27th. The company reported $0.05 earnings per share (EPS) for the quarter. The company had revenue of $3.54 billion for the quarter, compared to analyst estimates of $3.38 billion. Haleon had a net margin of 10.85% and a return on equity of 14.76%. Sell-side analysts predict that Haleon will post 0.43 earnings per share for the current year.

Haleon Increases Dividend

The business also recently declared a — dividend, which will be paid on Thursday, June 5th. Stockholders of record on Friday, April 25th will be issued a $0.1166 dividend. This is a positive change from Haleon’s previous — dividend of $0.05. The ex-dividend date of this dividend is Friday, April 25th. This represents a dividend yield of 1.6%. Haleon’s dividend payout ratio is presently 58.97%.

Institutional Investors Weigh In On Haleon

Institutional investors have recently made changes to their positions in the business. Procyon Advisors LLC boosted its stake in shares of Haleon by 41.3% in the 4th quarter. Procyon Advisors LLC now owns 230,240 shares of the company’s stock valued at $2,196,000 after purchasing an additional 67,329 shares in the last quarter. HighTower Advisors LLC boosted its stake in shares of Haleon by 27.2% in the 3rd quarter. HighTower Advisors LLC now owns 350,795 shares of the company’s stock valued at $3,701,000 after purchasing an additional 74,970 shares in the last quarter. Jane Street Group LLC boosted its stake in shares of Haleon by 1,689.4% in the 3rd quarter. Jane Street Group LLC now owns 264,977 shares of the company’s stock valued at $2,803,000 after purchasing an additional 250,169 shares in the last quarter. Chartwell Investment Partners LLC boosted its stake in shares of Haleon by 107.8% in the 3rd quarter. Chartwell Investment Partners LLC now owns 475,415 shares of the company’s stock valued at $5,030,000 after purchasing an additional 246,594 shares in the last quarter. Finally, Townsquare Capital LLC boosted its stake in shares of Haleon by 29.8% in the 3rd quarter. Townsquare Capital LLC now owns 475,618 shares of the company’s stock valued at $5,032,000 after purchasing an additional 109,217 shares in the last quarter. Hedge funds and other institutional investors own 6.67% of the company’s stock.

About Haleon

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.